Corrigendum to "Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with biliary tract cancer": [ESMO Open 9 (2024) 103647].

Saved in:
Bibliographic Details
Title: Corrigendum to "Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with biliary tract cancer": [ESMO Open 9 (2024) 103647].
Authors: Chen LT; Kaohsiung Medical University Hospital, Center for Cancer Research, Kaohsiung Medical University, Kaohsiung, Taiwan; National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan. Electronic address: leochen@nhri.org.tw., Vogel A; Department of Gastroenterology, Hepatology and Endocrinology, Medical School of Hannover, Hannover, Germany; Division of Gastroenterology and Hepatology, Toronto General Hospital, Medical Oncology, Princess Margaret Cancer Centre, Toronto, Canada., Hsu C; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan; Department of Medical Oncology, National Taiwan University Cancer Center, Taipei, Taiwan., Chen MH; Department of Oncology, Taipei Veterans General Hospital, Taipei, Taiwan., Fang W; Department of Medical Oncology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China., Pangarsa EA; Haematology Medical Oncology Division, Department of Oncology, Faculty of Medicine, Diponegoro University/Dr. Kariadi Hospital, Semarang, Indonesia., Sharma A; Department of Medical Oncology, Max Institute of Cancer Care, Max Super Specialty Hospital, Saket, New Delhi, India., Ikeda M; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, Kashiwa, Japan., Park JO; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea., Tan CK; Department of Oncology and Nuclear Medicine, Thomson Hospital Kota Damansara, Petaling Jaya, Selangor, Malaysia., Regala E; Clinical Division Building, University of Santo Tomas Hospital, Sampaloc, Manila, Philippines., Tai D; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore., Tanasanvimon S; Division of Medical Oncology, Department of Internal Medicine, Faculty of Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok., Charoentum C; Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand., Chee CE; Department of Haematology-Oncology, National University Cancer Institute, National University Health System, Singapore, Singapore., Lui A; Department of Internal Medicine, Metro Davao Medical and Research Center, Davao City, The Philippines; Section of Medical Oncology, Department of Internal Medicine, Southern Philippines Medical Center, Davao City, The Philippines., Sow J; Department of Oncology, Curie Oncology Kuala Lumpur, Kuala Lumpur, Malaysia., Oh DY; Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea., Ueno M; Department of Gastroenterology, Kanagawa Cancer Center, Yokohama, Japan., Ramaswamy A; Department of Medical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute, Parel, Mumbai, India., Jeo WS; Division of Digestive Surgery, Department of General Surgery, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia., Zhou J; Department of Gastrointestinal Oncology, Peking University Cancer Hospital & Institute, Beijing, China., Curigliano G; Istituto Europeo di Oncologia, Milano, IRCCS, Milano, Italy; Department of Oncology and Haematology, University of Milano, Milano, Italy., Yoshino T; Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan., Bai LY; Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, China Medical University, Taichung, Taiwan., Pentheroudakis G; ESMO, Lugano, Switzerland., Chiang NJ; Department of Oncology, Taipei Veterans General Hospital, Taipei, Taiwan., Cervantes A; Department of Medical Oncology, INCLIVA Biomedical Research Institute, University of Valencia, Valencia; CIBERONC. Instituto de Salud Carlos III, Madrid, Spain., Chen JS; Department of Internal Medicine, Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, Taiwan., Ducreux M; INSERM U1279, Université Paris-Saclay, Villejuif, France; Department of Cancer Medicine, Gustave Roussy, Villejuif, France.
Source: ESMO open [ESMO Open] 2025 Jan; Vol. 10 (1), pp. 104074. Date of Electronic Publication: 2024 Dec 19.
Publication Type: Published Erratum
Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE; PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2059-7029
DOI:10.1016/j.esmoop.2024.104074